Dose Response and Atypical Antipsychotics in Schizophrenia

ISSN： 1172-7047

Source： CNS Drugs, Vol.18, Iss.9, 2004-01, pp. : 597-616

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advantages of atypical antipsychotics in the maintenance treatment of schizophrenia

By Kissling W.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 188-188

Elsevier

Access to resources Recommend Favorite

Impact of Atypical Antipsychotics on Quality of Life in Patients with Schizophrenia

By Awad A. George

CNS Drugs, Vol. 18, Iss. 13, 2004-01 ,pp. : 877-893

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia

By Arranz Maria J.

CNS Drugs, Vol. 25, Iss. 11, 2011-11 ,pp. : 933-969

Adis International

Access to resources Recommend Favorite

Role of Newer Atypical Antipsychotics in the Management of Treatment- Resistant Schizophrenia

By Emsley R.A.

CNS Drugs, Vol. 13, Iss. 6, 2000-06 ,pp. : 409-420

Adis International

Access to resources Recommend Favorite

Advances in Atypical Antipsychotics for the Treatment of Schizophrenia: New Formulations and New Agents

By Kelleher J.P. Centorrino F. Albert M.J. Baldessarini R.J.

CNS Drugs, Vol. 16, Iss. 4, 2002-01 ,pp. : 249-261

Adis International

Access to resources Recommend Favorite